Commercially insured 18- to 64-year-old cancer patients often bear larger financial burdens than Medicare patients. "With the increases in rates we're seeing in commercially insured populations, and ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, ...

This test predicts cancer recurrence ... This represents an expansion from the prior Medicare coverage of Guardant Reveal testing for CRC only in the early post-surgical setting.

Source: Getty Images The amount Medicare pays for cancer drugs may be determined by the size of the anticipated treatment population rather than the actual therapeutic value of the drugs ...

Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Medicare covers inpatient and outpatient care for skin cancer. People with Original Medicare parts A and B or Medicare Advantage plans can expect extensive coverage, but they will likely have out ...

Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace" or the "Company") (OTCQX: IDXG) today announced notification that the Centers ...